Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

Author(s): Hirokazu Tamamura, Hiroshi Tsutsumi and Nobutaka Fujii

Volume 6, Issue 9, 2006

Page: [989 - 995] Pages: 7

DOI: 10.2174/138955706778195135

Price: $65

Abstract

CXCR4 is the receptor for a chemokine, CXCL12 (stromal cell-derived factor-1, SDF-1). The CXCL12- CXCR4 axis has been proven to be involved in several problematic diseases, including AIDS, cancer cell metastasis, leukemia cell progression and rheumatoid arthritis (RA). Thus, CXCR4 is thought to be an important therapeutic target to overcome the above diseases. We have developed several specific CXCR4 antagonists.

Keywords: Leukemia cell progression, cancer metastasis, chemokine receptor, HIV infection, low molecular weight CXCR4 antagonist, rheumatoid arthritis, T140, T22

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy